Trial intelligence / Profile preview

Effect of berberine on COVID-19

IRCT20081019001369N2Phase 2Completed

Sponsor
Mashhad University of Medical Sciences
Start
Apr 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of berberine in coronavirus disease 2019 (COVID-19), sponsored by Mashhad University of Medical Sciences. Started Apr 2020; status: completed.

02

Drugs

berberine
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on IRCT20081019001369N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20081019001369N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call